Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis-A Systematic Review.
Alentorn A, Berzero G, Alexopoulos H, Tzartos J, Reyes Botero G, Morales Martínez A, Muñiz-Castrillo S, Vogrig A, Joubert B, García Jiménez FA, Cabrera D, Tobon JV, Delgado C, Sandoval P, Troncoso M, Galleguillos L, Giry M, Benazra M, Hernández Verdin I, Dade M, Picard G, Rogemond V, Weiss N, Dalakas MC, Boëlle PY, Delattre JY, Honnorat J, Psimaras D. Alentorn A, et al. Among authors: hernandez verdin i. Biomedicines. 2023 May 25;11(6):1525. doi: 10.3390/biomedicines11061525. Biomedicines. 2023. PMID: 37371620 Free PMC article. Review.
Recent advances in the diagnosis and the treatment of primary CNS lymphoma.
Rachdi A, Hernandez-Tost H, Herzi D, Morales-Martinez A, Hernández-Verdin I, Houillier C, Alentorn A, Hoang-Xuan K. Rachdi A, et al. Among authors: hernandez verdin i. Rev Neurol (Paris). 2023 Jun;179(5):481-489. doi: 10.1016/j.neurol.2023.03.012. Epub 2023 Apr 10. Rev Neurol (Paris). 2023. PMID: 37045615 Review.
Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model.
Ahmed MH, Hernández-Verdin I, Quissac E, Lemaire N, Guerin C, Guyonnet L, Zahr N, Mouton L, Santin M, Petiet A, Schmitt C, Bouchoux G, Canney M, Sanson M, Verreault M, Carpentier A, Idbaih A. Ahmed MH, et al. Among authors: hernandez verdin i. Pharmaceutics. 2023 Jan 30;15(2):455. doi: 10.3390/pharmaceutics15020455. Pharmaceutics. 2023. PMID: 36839777 Free PMC article.
Molecular and clinical diversity in primary central nervous system lymphoma.
Hernández-Verdin I, Kirasic E, Wienand K, Mokhtari K, Eimer S, Loiseau H, Rousseau A, Paillassa J, Ahle G, Lerintiu F, Uro-Coste E, Oberic L, Figarella-Branger D, Chinot O, Gauchotte G, Taillandier L, Marolleau JP, Polivka M, Adam C, Ursu R, Schmitt A, Barillot N, Nichelli L, Lozano-Sánchez F, Ibañez-Juliá MJ, Peyre M, Mathon B, Abada Y, Charlotte F, Davi F, Stewart C, de Reyniès A, Choquet S, Soussain C, Houillier C, Chapuy B, Hoang-Xuan K, Alentorn A. Hernández-Verdin I, et al. Ann Oncol. 2023 Feb;34(2):186-199. doi: 10.1016/j.annonc.2022.11.002. Epub 2022 Nov 17. Ann Oncol. 2023. PMID: 36402300 Free article.
Prognostic factors in primary central nervous system lymphoma.
Morales-Martinez A, Nichelli L, Hernandez-Verdin I, Houillier C, Alentorn A, Hoang-Xuan K. Morales-Martinez A, et al. Among authors: hernandez verdin i. Curr Opin Oncol. 2022 Nov 1;34(6):676-684. doi: 10.1097/CCO.0000000000000896. Epub 2022 Sep 12. Curr Opin Oncol. 2022. PMID: 36093869 Review.